Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1974 Jun;53(6):1716–1725. doi: 10.1172/JCI107723

Digitalis-Induced Increase in Aortic Regurgitation and the Contrasting Effects of Glucagon in the Sedated Dog

Barry E Hopkins 1, Roger R Taylor 1
PMCID: PMC302668  PMID: 4830233

Abstract

The hemodynamic and phasic ascending aortic flow changes induced by acetylstrophanthidin and glucagon were studied in closed-chest sedated dogs with aortic regurgitation. While the positive inotropic effect of both agents was reflected in an increase in peak rate of rise of left ventricular pressure, acetylstrophanthidin increased aortic regurgitation, while glucagon decreased it. With the former, left ventricular end-diastolic pressure rose from 20±6 to 27±6 mm Hg (P < 0.005), but fell from 18±4 to 11±3 mm Hg (P < 0.001) with glucagon. Acetylstrophanthidin increased systemic vascular resistance, aortic diastolic pressure, and diastolic regurgitant flow rate, and, heart rate and the duration of regurgitation per beat and per minute being unchanged, regurgitant flow per beat increased 32±15% (P < 0.001). Glucagon decreased regurgitant flow per beat 27±14% (P < 0.001) because of abbreviation of diastole associated with tachycardia, and because of reduction in regurgitant flow rate. Despite tachycardia, the duration of regurgitation per minute was unchanged, and the small fall in regurgitant blood flow per minute was not significant, but this pertained in the face of 47% increase in effective cardiac output (P < 0.001). In contrast, acetylstrophanthidin increased regurgitant flow per minute 28±14% (P < 0.001) without change in effective cardiac output. The increase in cardiac contractility, tachycardia, and systemic vasodilatation induced by glucagon preferentially enhanced forward blood flow, which led to reduction in left ventricular volume overload, while it increased cardiac output. Contrarily, acetylstrophanthidin increased aortic regurgitation and, despite its inotropic effect, increased left ventricular volume overload without an increase in cardiac output.

Full text

PDF
1716

Images in this article

1720Image
on p.1720
1721Image
on p.1721
1722Image
on p.1722
1723Image
on p.1723

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong P. W., Gold H. K., Daggett W. M., Austen W. G., Sanders C. A. Hemodynamic evaluation of glucagon in symptomatic heart disease. Circulation. 1971 Jul;44(1):67–73. doi: 10.1161/01.cir.44.1.67. [DOI] [PubMed] [Google Scholar]
  2. BAYLISS R. I. S., ETHERIDGE M. J., HYMAN A. L., KELLY H. G., McMICHAEL J., REID E. A. S. The effect of digoxin on the right ventricular pressure in hypertensive and ischaemic heart failure. Br Heart J. 1950 Oct;12(4):317–326. doi: 10.1136/hrt.12.4.317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BRAUNWALD E., MASON D. T., ROSS J., Jr STUDIES ON THE CARDIOCIRCULATORY ACTIONS OF DIGITALIS. Medicine (Baltimore) 1965 May;44:233–248. doi: 10.1097/00005792-196505000-00002. [DOI] [PubMed] [Google Scholar]
  4. Bache R. J., McHale P. A., Curry C. L., Alexander J. A., Greenfield J. C., Jr Coronary and systemic hemodynamic effects of glucagon in the intact unanesthetized dog. J Appl Physiol. 1970 Dec;29(6):769–774. doi: 10.1152/jappl.1970.29.6.769. [DOI] [PubMed] [Google Scholar]
  5. Bloomfield R. A., Rapoport B., Milnor J. P., Long W. K., Mebane J. G., Ellis L. B., Lavin M. R. THE EFFECTS OF THE CARDIAC GLYCOSIDES UPON THE DYNAMICS OF THE CIRCULATION IN CONGESTIVE HEART FAILURE. I. OUABAIN. J Clin Invest. 1948 Sep;27(5):588–599. doi: 10.1172/JCI102004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Braunwald E., Bloodwell R. D., Goldberg L. I., Morrow A. G. STUDIES ON DIGITALIS. IV. OBSERVATIONS IN MAN ON THE EFFECTS OF DIGITALIS PREPARATIONS ON THE CONTRACTILITY OF THE NON-FAILING HEART AND ON TOTAL VASCULAR RESISTANCE. J Clin Invest. 1961 Jan;40(1):52–59. doi: 10.1172/JCI104236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brawley R. K., Morrow A. G. Direct determinations of aortic blood flow in patients with aortic regurgitation. Effects of alterations in heart rate, increased ventricular preload or afterload, and isoproterenol. Circulation. 1967 Jan;35(1):32–45. doi: 10.1161/01.cir.35.1.32. [DOI] [PubMed] [Google Scholar]
  8. Cohn J. N., Tristani F. E., Khatri I. M. Cardiac and peripheral vascular effects of digitalis in clinical cardiogenic shock. Am Heart J. 1969 Sep;78(3):318–330. doi: 10.1016/0002-8703(69)90039-8. [DOI] [PubMed] [Google Scholar]
  9. Diamond G., Forrester J., Danzig R., Parmley W. W., Swan H. J. Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man. Br Heart J. 1971 Mar;33(2):290–295. doi: 10.1136/hrt.33.2.290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ettinger P. O., Frank M. J., Levinson G. E. Hemodynamics at rest and during exercise in combined aortic stenosis and insufficiency. Circulation. 1972 Feb;45(2):267–276. doi: 10.1161/01.cir.45.2.267. [DOI] [PubMed] [Google Scholar]
  11. FARAH A., TUTTLE R. Studies on the pharmacology of glucagon. J Pharmacol Exp Ther. 1960 May;129:49–55. [PubMed] [Google Scholar]
  12. GORLIN R., McMILLAN I. K., MEDD W. E., MATTHEWS M. B., DALEY R. Dynamics of the circulation in aortic valvular disease. Am J Med. 1955 Jun;18(6):855–870. doi: 10.1016/0002-9343(55)90169-8. [DOI] [PubMed] [Google Scholar]
  13. Gold H. K., Prindle K. H., Levey G. S., Epstein S. E. Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase. J Clin Invest. 1970 May;49(5):999–1006. doi: 10.1172/JCI106319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goldschlager N., Robin E., Cowan C. M., Leb G., Bing R. J. The effect of glucagon on the coronary circulation in man. Circulation. 1969 Dec;40(6):829–837. doi: 10.1161/01.cir.40.6.829. [DOI] [PubMed] [Google Scholar]
  15. Greenberg B. H., Tsakiris A. G., Moffitt E. A., Frye R. L. The hemodynamic and metabolic effects of glucagon in patients with chronic valvular heart disease. Mayo Clin Proc. 1970 Feb;45(2):132–139. [PubMed] [Google Scholar]
  16. Higgins C. B., Vatner S. F., Braunwald E. Regional hemodynamic effects of a digitalis glycoside in the conscious dog with and without experimental heart failure. Circ Res. 1972 Apr;30(4):406–417. doi: 10.1161/01.res.30.4.406. [DOI] [PubMed] [Google Scholar]
  17. Hood W. B., Jr, McCarthy B., Lown B. Myocardial infarction following coronary ligation in dogs. Hemodynamic effects of isoproterenol and acetylstrophanthidin. Circ Res. 1967 Aug;21(2):191–199. doi: 10.1161/01.res.21.2.191. [DOI] [PubMed] [Google Scholar]
  18. Hopkins B. E., Taylor R. R. Influence of various catecholamines on aortic regurgitation. J Appl Physiol. 1973 Mar;34(3):309–317. doi: 10.1152/jappl.1973.34.3.309. [DOI] [PubMed] [Google Scholar]
  19. Judge T. P., Kennedy J. W., Bennett L. J., Wills R. E., Murray J. A., Blackmon J. R. Quantitative hemodynamic effects of heart rate in aortic regurgitation. Circulation. 1971 Sep;44(3):355–367. doi: 10.1161/01.cir.44.3.355. [DOI] [PubMed] [Google Scholar]
  20. Karliner J. S., Braunwald E. Present status of digitalis treatment of acute myocardial infarction. Circulation. 1972 Apr;45(4):891–902. doi: 10.1161/01.cir.45.4.891. [DOI] [PubMed] [Google Scholar]
  21. Kones R. J., Phillips J. H. Glucagon: present status in cardiovascular disease. Clin Pharmacol Ther. 1971 May-Jun;12(3):427–444. doi: 10.1002/cpt1971123427. [DOI] [PubMed] [Google Scholar]
  22. Linhart J. W., Barold S. S., Cohen L. S., Hildner F. J., Samet P. Cardiovascular effects of glucagon in man. Am J Cardiol. 1968 Nov;22(5):706–710. doi: 10.1016/0002-9149(68)90209-9. [DOI] [PubMed] [Google Scholar]
  23. Lucchesi B. R. Cardiac actions of glucagon. Circ Res. 1968 Jun;22(6):777–787. doi: 10.1161/01.res.22.6.777. [DOI] [PubMed] [Google Scholar]
  24. Lvoff R., Wilcken D. E. Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients. Circulation. 1972 Mar;45(3):534–542. doi: 10.1161/01.cir.45.3.534. [DOI] [PubMed] [Google Scholar]
  25. MASON D. T., BRAUNWALD E. STUDIES ON DIGITALIS. X. EFFECTS OF OUABAIN ON FOREARM VASCULAR RESISTANCE AND VENOUS TONE IN NORMAL SUBJECTS AND IN PATIENTS IN HEART FAILURE. J Clin Invest. 1964 Mar;43:532–543. doi: 10.1172/JCI104939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Manchester J. H., Parmley W. W., Matloff J. M., Leidtke A. J., LaRaia P. J., Herman M. V., Sonnenblock E. H., Gorlin R. Effects of glucagon on myocardial oxygen consumption and coronary blood flow in man and in dog. Circulation. 1970 Apr;41(4):579–588. doi: 10.1161/01.cir.41.4.579. [DOI] [PubMed] [Google Scholar]
  27. Puri P. S., Bing R. J. Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock. Am Heart J. 1969 Nov;78(5):660–668. doi: 10.1016/0002-8703(69)90518-3. [DOI] [PubMed] [Google Scholar]
  28. Sonnenblick E. H., Ross J., Jr, Braunwald E. Oxygen consumption of the heart. Newer concepts of its multifactoral determination. Am J Cardiol. 1968 Sep;22(3):328–336. doi: 10.1016/0002-9149(68)90117-3. [DOI] [PubMed] [Google Scholar]
  29. Taylor R. R., Hopkins B. E. Influence of respiration and respiratory sinus arrhythmia on aortic regurgitation. Am J Physiol. 1972 Sep;223(3):668–672. doi: 10.1152/ajplegacy.1972.223.3.668. [DOI] [PubMed] [Google Scholar]
  30. Taylor R. R., Hopkins B. E. Left ventricular response to experimentally induced chronic aortic regurgitation. Cardiovasc Res. 1972 Jul;6(4):404–414. doi: 10.1093/cvr/6.4.404. [DOI] [PubMed] [Google Scholar]
  31. Vatner S. F., Higgins C. B., Franklin D., Braunwald E. Effects of a digitalis glycoside on coronary and systemic dynamics in conscious dogs. Circ Res. 1971 Apr;28(4):470–479. doi: 10.1161/01.res.28.4.470. [DOI] [PubMed] [Google Scholar]
  32. Vatner S. F., Higgins C. B., Patrick T., Franklin D., Braunwald E. Effects of cardiac depression and of anesthesia on the myocardial action of a cardiac glycoside. J Clin Invest. 1971 Dec;50(12):2585–2595. doi: 10.1172/JCI106759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Williams J. F., Jr, Childress R. H., Chip J. N., Border J. F. Hemodynamic effects of glucagon in patients with heart disease. Circulation. 1969 Jan;39(1):38–47. doi: 10.1161/01.cir.39.1.38. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES